Syros Pharmaceuticals Inc. (NASDAQ: SYRS) Stock Information | RedChip

Syros Pharmaceuticals Inc. (NASDAQ: SYRS) Listen to this Section


$1.54
+0.0100 ( +0.65% ) 213.5K

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Market Data


Open


$1.54

Previous close


$1.53

Volume


213.5K

Market cap


$41.56M

Day range


$1.51 - $1.62

52 week range


$1.48 - $8.17

Insider Ownership Transactions

Total Amount Purchased: -240,449.00 | $ -370,291.46

Date Type Amount Purchased Purchaser
2023-12-14 Sale -6287.00 Roth David
2023-12-08 Sale -6287.00 Roth David
2023-12-05 Sale -7500.00 Simonian Nancy A
2023-12-05 Sale -86000.00 Chee Conley
2023-11-02 Sale -18875.00 Haas Jason
2023-11-02 Sale -40125.00 Simonian Nancy A
2023-11-02 Sale -17000.00 Chee Conley
2023-11-02 Sale -17000.00 Stephens Kristin
2023-11-02 Sale -18875.00 Roth David
2023-10-20 Sale -22500.00 Quirk Gerald E

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
10-k Annual reports 116 Mar 27, 2024
8-k 8K-related 32 Jan 08, 2024
4 Insider transactions 1 Dec 26, 2023
8-k 8K-related 19 Dec 19, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.